The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
Clinical trial NCT06656962 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06656962
- Sponsor
- Renmin Hospital of Wuhan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2025-12-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.